The risk of hemorrhage among patients with warfarin-associated coagulopathy.

[1]  J. Hirsh,et al.  The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[2]  E. Hylek.  Trends in Anticoagulation Management Across Community-Based Practices in the United States: The Anticoagulation Consortium to Improve Outcomes Nationally (ACTION) Study , 2003, Journal of Thrombosis and Thrombolysis.

[3]  M. Crowther,et al.  Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. , 2004, Thrombosis research.

[4]  Yuchiao Chang,et al.  Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.

[5]  D. Garcia,et al.  A survey of oral vitamin K use by anticoagulation clinics. , 2002, Archives of internal medicine.

[6]  J. Douketis,et al.  Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy , 2002, Annals of Internal Medicine.

[7]  J. Hirsh,et al.  Managing oral anticoagulant therapy. , 2001, Chest.

[8]  J. Douketis,et al.  Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial , 2000, The Lancet.

[9]  B. Gage,et al.  Management and dosing of warfarin therapy. , 2000, The American journal of medicine.

[10]  D. Witt,et al.  Randomized, Placebo‐Controlled Trial of Oral Phytonadione for Excessive Anticoagulation , 2000, Pharmacotherapy.

[11]  D. Singer,et al.  Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. , 2000, Archives of internal medicine.

[12]  P. Petersen,et al.  Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. , 1999, Archives of internal medicine.

[13]  M. Crowther,et al.  Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin , 1998, Thrombosis and Haemostasis.

[14]  D. Malone,et al.  Evaluation of excessive anticoagulation in a group model health maintenance organization. , 1998, Archives of internal medicine.

[15]  S. Rapaport,et al.  Correction of Excessive Anticoagulation with Low-Dose Oral Vitamin K1 , 1997, Annals of Internal Medicine.

[16]  Vittorio Pengo,et al.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.

[17]  J. Glover,et al.  Conservative treatment of overanticoagulated patients. , 1995, Chest.

[18]  J. Vandenbroucke,et al.  Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.

[19]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[20]  L Goldman,et al.  Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions. , 1989, The American journal of medicine.

[21]  L Goldman,et al.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[22]  J. Hirsh,et al.  RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT , 1988, The Lancet.

[23]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[24]  G. Raskob,et al.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. , 1982, The New England journal of medicine.

[25]  D. Tweedle.  INTRAVENOUS FAT , 1976, The Lancet.